Diabetic foot is one of the most challenging and complex conditions in modern medicine. Effective healing of a diabetic wound requires the precise synchronization of more than 30 physiological and clinical processes - much like a philharmonic orchestra working in perfect harmony.
In response to the significant clinical challenges and the lack of comprehensive treatment solutions, TriO was founded. The company has developed a novel, integrated device designed to address the multiple therapeutic actions required for diabetic foot treatment simultaneously. The device is designed for ease of use and can be operated in hospitals or clinics at the optimal time to support the healing process.
When implemented as part of a treatment protocol for diabetic foot ulcer (DFU) patients, the solution has the potential to significantly improve patient outcomes, reduce the risk of amputation, and support quality of life for people living with diabetes worldwide.
Our Vision
To fundamentally change medical care and significantly reduce physical and emotional suffering for DFU patients worldwide.
Our Mission
To enable DFU's patients to be treated with an innovative, effective and affordable medical solution that will improve their health at the most critical stages of healing.
The Key Advantages that Open the Door for Tri.O
Addressing a major medical challenge, our solution
is a breakthrough that offers a paradigm shift in the treatment
of Diabetic Foot Ulcers (DFU).
Improving the quality and life expectancy of patients.
User-friendly and affordable, the device is intended for use in clinical settings to support treatment.
FITT Treats DFU using 3 distinct methods for improved outcomes and treatment :
Compression therapy - evacuates the edema from the ulcer
Negative Pressure - increases blood flow to the ulcer
Disinfection with a mixture of Oxygen & Ozone
Our Story
"We love people more for the good we have done them than for the good they have done us."
Leo Tolstoy
The three founders of the project, leading experts in their field, made it their mission driven by a desire to act. A combination of professional curiosity, personal experience with the phenomenon, and a desire to bring something good into the world brought together the key players in this important medical project.
Join Us in Revolutionizing
DFU Treatment Worldwide
The Global Diabetes Epidemic:
-
Over 537 million people currently live with diabetes worldwide.
-
This number is expected to reach 700 million by 2045.
-
25% of people with diabetes will develop DFU, with a 5-year mortality rate of 42%.
-
More than half of DFU patients will develop an infection, leading to 17% undergoing amputation as a treatment.
-
Fear of amputation is greater than fear of death for most diabetic foot patients.
-
The global cost of diabetes in 2015 was estimated at $1.3 trillion.
-
Nearly one-third of direct diabetes costs are attributed to DFU treatment.
